519 related articles for article (PubMed ID: 36841799)
1. Is there a causal nexus between COVID-19 infection, COVID-19 vaccination, and Guillain-Barré syndrome?
Zheng X; Fang Y; Song Y; Liu S; Liu K; Zhu J; Wu X
Eur J Med Res; 2023 Feb; 28(1):98. PubMed ID: 36841799
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 as a trigger of Guillain-Barré syndrome: A review of the molecular mechanism.
Malekpour M; Khanmohammadi S; Meybodi MJE; Shekouh D; Rahmanian MR; Kardeh S; Azarpira N
Immun Inflamm Dis; 2023 May; 11(5):e875. PubMed ID: 37249286
[TBL] [Abstract][Full Text] [Related]
3. The challenge of diagnosing Guillain-Barre syndrome in patients with COVID-19 in the intensive care unit.
Diaz P; Leveque M; Hautecloque G; Sellal F; Augereau O; Lita L; Biegle E; Belilita L; Bouterra C; Rerat P; Alvarez-Gonzalez A; Martinot M; Gerber V
J Neuroimmunol; 2022 May; 366():577842. PubMed ID: 35339941
[TBL] [Abstract][Full Text] [Related]
4. Concomitant Guillain-Barré Syndrome and COVID-19: A Meta-Analysis of Cases.
Bentley SA; Ahmad S; Kobeissy FH; Toklu HZ
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557036
[No Abstract] [Full Text] [Related]
5. Guillain-Barré Syndrome Associated with COVID-19 Vaccination.
Shao SC; Wang CH; Chang KC; Hung MJ; Chen HY; Liao SC
Emerg Infect Dis; 2021 Dec; 27(12):3175-3178. PubMed ID: 34648420
[TBL] [Abstract][Full Text] [Related]
6. A 50-Year-Old Patient with Guillain-Barré Syndrome after COVID-19: A Case Report.
Chmiela T; Rzepka M; Krzystanek E; Gorzkowska A
Medicina (Kaunas); 2021 Jul; 57(8):. PubMed ID: 34440980
[TBL] [Abstract][Full Text] [Related]
7. Is Guillain-Barrè syndrome triggered by SARS-CoV-2? Case report and literature review.
Agosti E; Giorgianni A; D'Amore F; Vinacci G; Balbi S; Locatelli D
Neurol Sci; 2021 Feb; 42(2):607-612. PubMed ID: 32643136
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy.
Baars AE; Kuitwaard K; de Koning LC; Luijten LWG; Kok WM; Eftimov F; Wieske L; Goedee HS; van der Pol WL; Blomkwist-Markens PH; Horemans AMC; Jacobs BC; van Doorn PA
Neurology; 2023 Jan; 100(2):e182-e191. PubMed ID: 36127144
[TBL] [Abstract][Full Text] [Related]
9. Guillain-Barré syndrome after COVID-19 vaccination: A systematic review and analysis of case reports.
Abuawwad MT; Taha MJJ; Taha AJ; Kozaa YA; Falah O; Abuawwad IT; Hammad EM; Mahmoud AA; Aladawi M; Serhan HA
Clin Neurol Neurosurg; 2024 Mar; 238():108183. PubMed ID: 38401232
[TBL] [Abstract][Full Text] [Related]
10. Association Between Guillain-Barré Syndrome and COVID-19 Infection and Vaccination: A Population-Based Nested Case-Control Study.
Bishara H; Arbel A; Barnett-Griness O; Bloch S; Cohen S; Najjar-Debbiny R; Gronich N; Auriel E; Saliba W
Neurology; 2023 Nov; 101(20):e2035-e2042. PubMed ID: 37852786
[TBL] [Abstract][Full Text] [Related]
11. Acute-onset chronic inflammatory demyelinating polyneuropathy after COVID-19 infection and subsequent ChAdOx1 nCoV-19 vaccination.
Suri V; Pandey S; Singh J; Jena A
BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34607818
[TBL] [Abstract][Full Text] [Related]
12. [Urodynamic AUR in Guillain-Barré syndrome post-infection by coronavirus Sars-CoV-2. A bibliographic review.].
Méndez-Rubio S; Laso-Martín S; Jerez-Izquierdo T; Lorenzo-García C; López-Pérez E; Vives-Dilme R; Fernández-Hernández L; Méndez-Cea B; Moreno-Sierra J; Virseda-Chamorro M; Salinas-Casado J
Arch Esp Urol; 2022 Jan; 75(1):7-18. PubMed ID: 35173070
[TBL] [Abstract][Full Text] [Related]
13. Guillain-Barré syndrome associated with SARS-CoV-2 infection: A systematic review and individual participant data meta-analysis.
Hasan I; Saif-Ur-Rahman KM; Hayat S; Papri N; Jahan I; Azam R; Ara G; Islam Z
J Peripher Nerv Syst; 2020 Dec; 25(4):335-343. PubMed ID: 33112450
[TBL] [Abstract][Full Text] [Related]
14. Guillain-Barré syndrome in an era of global infections and 21st century vaccination.
Lunn MP
Curr Opin Neurol; 2022 Oct; 35(5):571-578. PubMed ID: 36069416
[TBL] [Abstract][Full Text] [Related]
15. Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study.
Luijten LWG; Leonhard SE; van der Eijk AA; Doets AY; Appeltshauser L; Arends S; Attarian S; Benedetti L; Briani C; Casasnovas C; Castellani F; Dardiotis E; Echaniz-Laguna A; Garssen MPJ; Harbo T; Huizinga R; Humm AM; Jellema K; van der Kooi AJ; Kuitwaard K; Kuntzer T; Kusunoki S; Lascano AM; Martinez-Hernandez E; Rinaldi S; Samijn JPA; Scheidegger O; Tsouni P; Vicino A; Visser LH; Walgaard C; Wang Y; Wirtz PW; Ripellino P; Jacobs BC;
Brain; 2021 Dec; 144(11):3392-3404. PubMed ID: 34553216
[TBL] [Abstract][Full Text] [Related]
16. Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases.
Abu-Rumeileh S; Abdelhak A; Foschi M; Tumani H; Otto M
J Neurol; 2021 Apr; 268(4):1133-1170. PubMed ID: 32840686
[TBL] [Abstract][Full Text] [Related]
17. Post coronavirus disease-2019 vaccination Guillain-Barré syndrome.
Biswas A; Pandey SK; Kumar D; Vardhan H
Indian J Public Health; 2021; 65(4):422-424. PubMed ID: 34975092
[TBL] [Abstract][Full Text] [Related]
18. [The first Hungarian patient with Guillain-Barre syndrome after COVID-19].
Al-Muhanna N; Béres-Molnár AK; Jarecsny T; Folyovich A
Ideggyogy Sz; 2021 Jan; 74(1-2):64-66. PubMed ID: 33497053
[TBL] [Abstract][Full Text] [Related]
19. A Case Report of Guillain-Barré Syndrome In Association with SARS-CoV-2 Vaccination in Malaysia.
Sii HL; Ng SH; Wong VF; Law WC
Acta Neurol Taiwan; 2023 Dec; 32(4)():207-211. PubMed ID: 37723913
[TBL] [Abstract][Full Text] [Related]
20. Guillain-Barré Syndrome Associated with SARS CoV-2 Infection: Case Report.
Nigatu D; Tigabu T; Awraris M; Yohannes A; Kebede D
Ethiop J Health Sci; 2022 Jan; 32(1):205-208. PubMed ID: 35250231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]